Cynosure Group LLC trimmed its stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD – Free Report) by 60.8% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 485 shares of the medical instruments supplier’s stock after selling 753 shares during the quarter. Cynosure Group LLC’s holdings in Mettler-Toledo International were worth $595,000 at the end of the most recent quarter.
A number of other hedge funds also recently bought and sold shares of MTD. Vanguard Group Inc. grew its position in shares of Mettler-Toledo International by 0.5% during the second quarter. Vanguard Group Inc. now owns 2,556,707 shares of the medical instruments supplier’s stock worth $3,003,415,000 after buying an additional 13,342 shares in the last quarter. Bank of New York Mellon Corp lifted its stake in Mettler-Toledo International by 71.3% in the second quarter. Bank of New York Mellon Corp now owns 904,264 shares of the medical instruments supplier’s stock worth $1,062,257,000 after acquiring an additional 376,419 shares during the last quarter. Alliancebernstein L.P. grew its holdings in Mettler-Toledo International by 1.1% during the 2nd quarter. Alliancebernstein L.P. now owns 717,449 shares of the medical instruments supplier’s stock worth $842,802,000 after acquiring an additional 8,121 shares in the last quarter. Geode Capital Management LLC grew its holdings in Mettler-Toledo International by 0.6% during the 2nd quarter. Geode Capital Management LLC now owns 581,847 shares of the medical instruments supplier’s stock worth $681,489,000 after acquiring an additional 3,383 shares in the last quarter. Finally, Fiera Capital Corp increased its position in shares of Mettler-Toledo International by 19.0% in the 2nd quarter. Fiera Capital Corp now owns 342,837 shares of the medical instruments supplier’s stock valued at $402,737,000 after purchasing an additional 54,740 shares during the last quarter. Institutional investors and hedge funds own 95.07% of the company’s stock.
Analyst Ratings Changes
MTD has been the subject of a number of analyst reports. Stifel Nicolaus boosted their target price on shares of Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the stock a “buy” rating in a research note on Monday, November 10th. Morgan Stanley initiated coverage on Mettler-Toledo International in a report on Tuesday, December 2nd. They set an “equal weight” rating and a $1,550.00 price target for the company. Evercore ISI increased their price objective on Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the company an “outperform” rating in a report on Tuesday, October 7th. Wells Fargo & Company boosted their target price on Mettler-Toledo International from $1,400.00 to $1,450.00 and gave the stock an “equal weight” rating in a research note on Monday, December 15th. Finally, The Goldman Sachs Group initiated coverage on Mettler-Toledo International in a report on Tuesday, December 9th. They issued a “neutral” rating and a $1,475.00 price target for the company. Six equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $1,441.67.
Mettler-Toledo International Stock Up 1.3%
MTD opened at $1,411.83 on Monday. Mettler-Toledo International, Inc. has a 52 week low of $946.69 and a 52 week high of $1,525.17. The business’s 50 day moving average is $1,420.77 and its two-hundred day moving average is $1,318.67. The firm has a market cap of $28.84 billion, a price-to-earnings ratio of 35.21, a price-to-earnings-growth ratio of 4.20 and a beta of 1.41.
Mettler-Toledo International (NYSE:MTD – Get Free Report) last announced its earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 EPS for the quarter, beating analysts’ consensus estimates of $10.62 by $0.53. The business had revenue of $1.03 billion for the quarter, compared to analysts’ expectations of $997.36 million. Mettler-Toledo International had a net margin of 21.20% and a negative return on equity of 426.96%. The company’s quarterly revenue was up 7.9% on a year-over-year basis. During the same period in the previous year, the company posted $10.21 EPS. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS and its FY 2025 guidance at 42.050-42.250 EPS. Equities analysts expect that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.
Insider Transactions at Mettler-Toledo International
In other Mettler-Toledo International news, Director Elisha W. Finney sold 474 shares of the company’s stock in a transaction that occurred on Monday, November 10th. The stock was sold at an average price of $1,433.57, for a total transaction of $679,512.18. Following the completion of the sale, the director directly owned 311 shares of the company’s stock, valued at $445,840.27. This represents a 60.38% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider La Guerroniere Marc De sold 6,880 shares of Mettler-Toledo International stock in a transaction that occurred on Tuesday, November 11th. The shares were sold at an average price of $1,450.00, for a total value of $9,976,000.00. Following the completion of the transaction, the insider owned 187 shares in the company, valued at $271,150. This trade represents a 97.35% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 19,565 shares of company stock worth $28,683,737 over the last three months. 0.77% of the stock is currently owned by company insiders.
Mettler-Toledo International Profile
Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.
The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.
See Also
- Five stocks we like better than Mettler-Toledo International
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- The $100 Trillion AI Story No One Is Telling You
- 3 Overlooked Deductions to Help Potentially Minimize Capital Gains Tax
- First Time Since 2007: All Warnings Active
Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International, Inc. (NYSE:MTD – Free Report).
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.
